Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
540737-29-9
Purity
95%
Tofacitinib is an inhibitor of Janus kinases, a group of intracellular enzymes involved in signalling pathways that affect hematopoiesis and immune cell function. It is used for the treatment of moderate to severe rheumatoid arthritis which is resistant or intolerant to methotrexate therapy. It may also be used as an adjunct to methotrexate therapy, or other non-biologic disease-modifying antirheumatic drugs, when methotrexate alone is not sufficient.
Properties
Name
Tofacitinib citrate
Smiles
C[C@@H]1CCN(C[C@@H]1N(C)C=2N=CN=C3NC=CC23)C(=O)CC#N.OC(=O)CC(O)(CC(=O)O)C(=O)O
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
CP-690550 | CP-690550 citrate | Tofacitinib citrate | tofacitib citrate | xeljanz XR
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$64
45 mg
$21
50 mg
$22
75 mg
$POA
100 mg
$POA
Quantity
1
Total amount
$ 19
CP-690550 | CP-690550 citrate | Tofacitinib citrate | tofacitib citrate | xeljanz XR
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.